Shares of Bristol-Myers Squibb Co. (BMY) fell more than 16 percent Friday after the company announced that its Opdivo drug failed a study that would have expanded its use to lung cancer patients. BMY stock dropped more than $12 a …
Bristol-Myers investors are paid a 2.45% dividend. Credit Suisse puts a $68 price target on the stock. The consensus target is much lower at $63.41. Shares closed trading Thursday at $60.23. Another top company in the health care …
Carl Icahn didn't amass a net worth of an estimated $16.6 billion by making dumb moves. So when Dow Jones reported that the billionaire bought a stake in Bristol-Myers Squibb (NYSE: BMY), it captured the attention of the investment …
NEW YORK (CNN/Money) - Bristol-Myers Squibb is battered black and blue, and it just got punched in the gut again. But one industry watcher thinks the drugmaker can retrace its way back from a series of management missteps and effect …
In addition, shareholders with beneficial ownership of approximately 17% of Inhibitex’s common stock have entered into agreements with Bristol-Myers Squibb to support the transaction and to tender their shares in the tender offer. …
The fall is all around us - this Sunday is the autumnal equinox and last Sunday spelled the end of Summers - yet stocks still stubbornly refuse to drop. S&P 500 Index (INDEXSP:.INX) shares advanced 1.98% and have now risen in nine of 10 …
NEW DELHI: Biocon Ltd surged over 2 per cent in trade on Friday after the India's premier biotechnology company announced its partnership with Bristol-Myers Squibb Company. At 09:50 am, Biocon pared most of its early …
CHICAGO, Sept. 14, 2017 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BMY, CLF, HTZ, …
Let’s analyze the factors that have driven the stock’s rally so far ... Rubraca in combination with Roche’s Tecentriq in gynecologic cancers or Bristol-Myers Squibb Company’s (BMY - Free Report) Opdivo in ovarian, breast and prostate …
BMY is a stock I ... the opinions of Interactive Investor Trading Limited or its affiliates and has not been approved or issued by Interactive Investor Trading Limited. You should be aware that the other participants of the above discussion group …